Notably, PTEN expression is often reduced in the disease through several other modes of PTEN regulation, for example, microRNAs, epigenetic modifications and ubiquitination6, 7, 8, 9, which likely contribute to the high frequency of Akt phosphorylation in myeloid leukaemia. This evidence concerns the gene AKT1 and myeloid leukemia.